P&G Hygiene

₹13860 95.3 | 0.7%

WEBSITE BSE:500459 NSE : PROCTER &GAM 09 Jun, 14:31

Market Cap ₹44991 Cr.

Stock P/E 79.0

P/B 42.7

Current Price ₹13860

Book Value ₹ 324.7

Face Value 10

52W High ₹15500

Dividend Yield 1.15%

52W Low ₹ 13100

Edit Ratio

P&G Hygiene Research see more...

Overview Inc. Year: 1964Industry: Household & Personal Products

Procter & Gamble Hygiene and Health Care Limited is engaged in the production and promoting of branded packaged FMCG inside the feminine care and healthcare companies. The Company's segments include Healthcare merchandise and Hygiene merchandise. The Healthcare merchandise section consists of ointment and creams, cough drops and tablets. The Hygiene merchandise section consists of feminine hygiene merchandise and different skin care hygiene merchandise. It gives ayurvedic products, sanitary napkins, and deodorants. Its portfolio of manufacturers includes Whisper, Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler and Vicks BabyRub. The Company's merchandise are bought thru retail operations inclusive of mass merchandisers, grocery stores, club membership shops, drug shops, branch stores and, high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, aside from third party manufacturing locations spread across India.

P&G Hygiene Share Price

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

P&G Hygiene Quarterly Results

#(Fig in Cr.)	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Net Sales	1018	760	787	1058	1093	973	776	1045	1137	883
Other Income	9	15	6	6	7	6	6	7	9	14
Total Income	1028	774	792	1064	1100	979	782	1052	1147	898
Total Expenditure	676	631	712	757	797	808	709	831	847	734
Operating Profit	352	143	81	307	303	171	73	221	300	164
Interest	2	3	1	1	3	7	1	1	4	4
Depreciation	12	11	13	13	13	13	14	14	14	15
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	338	129	67	294	288	151	58	206	282	146
Provision for Tax	87	31	18	76	75	48	15	51	74	-19
Profit After Tax	251	98	49	218	212	103	43	154	207	165
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	251	98	49	218	212	103	43	154	207	165
Adjusted Earnings Per Share	77.2	30.3	15.1	67.2	65.3	31.7	13.1	47.6	63.9	50.8

P&G Hygiene Profit & Loss

#(Fig in Cr.)	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	TTM
Net Sales	1297	1687	2051	2334	2275	2320	2455	2947	3002	3574	3901	3841
Other Income	51	67	80	76	88	79	24	55	44	56	30	36
Total Income	1349	1754	2131	2409	2363	2399	2479	3002	3046	3630	3931	3879
Total Expenditure	1098	1437	1630	1850	1670	1658	1840	2339	2398	2706	3077	3121
Operating Profit	251	318	501	559	693	742	639	663	648	924	854	758
Interest	0	0	5	6	6	10	5	5	6	6	11	10
Depreciation	28	31	35	53	52	60	52	50	48	48	53	57
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	223	286	460	501	636	672	582	607	594	870	790	692
Provision for Tax	42	83	158	155	213	239	207	188	161	218	214	121
Profit After Tax	181	203	302	346	423	433	375	419	433	652	576	569
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	181	203	302	346	423	433	375	419	433	652	576	569
Adjusted Earnings Per Share	55.9	62.6	93	106.6	130.2	133.3	115.4	129.1	133.4	200.8	177.4	175.4

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	9%	10%	11%	12%
Operating Profit CAGR	-8%	9%	3%	13%
PAT CAGR	-12%	11%	6%	12%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	1%	12%	8%	16%
ROE Average	83%	66%	61%	45%
ROCE Average	110%	87%	84%	63%

P&G Hygiene Balance Sheet

#(Fig in Cr.)	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022
Shareholder's Funds	697	805	1003	1229	1652	526	806	909	1158	714	738
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	369	-0	-4	-1	-5	25	26	29	46	45	34
Total Current Liabilities	399	441	502	716	511	582	571	642	595	835	858
Total Liabilities	1465	1246	1501	1944	2157	1134	1402	1580	1799	1595	1629
Fixed Assets	198	215	240	309	317	286	250	234	207	184	164
Other Non-Current Assets	497	191	249	278	208	245	316	256	264	294	332
Total Current Assets	769	841	1012	1357	1632	603	815	1069	1321	1117	1134
Total Assets	1465	1246	1501	1944	2157	1134	1402	1580	1799	1595	1629

P&G Hygiene Cash Flow

#(Fig in Cr.)	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022
Opening Cash & Cash Equivalents	125	173	161	266	615	1067	102	392	526	884	648
Cash Flow from Operating Activities	180	104	335	426	352	445	415	413	474	863	573
Cash Flow from Investing Activities	-46	-32	-135	28	221	149	-19	34	75	7	-27
Cash Flow from Financing Activities	-85	-85	-95	-105	-122	-1559	-106	-314	-190	-1106	-569
Net Cash Inflow / Outflow	49	-13	105	349	452	-964	290	134	358	-236	-23
Closing Cash & Cash Equivalent	173	161	266	615	1067	102	392	526	884	648	625

P&G Hygiene Ratios

#	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022
Earnings Per Share (Rs)	55.85	62.61	93.04	106.64	130.16	133.31	115.4	129.12	133.42	200.8	177.37
CEPS(Rs)	64.5	72.25	103.88	122.82	146.08	151.72	131.53	144.46	148.17	215.48	193.66
DPS(Rs)	22.5	25	27.5	30.25	36	389	40	88	105	315	160
Book NAV/Share(Rs)	214.74	248.1	308.96	378.52	507.78	159.65	244.05	274.67	349.7	210.9	214.95
Core EBITDA Margin(%)	15.32	14.72	20.34	20.49	25.79	27.4	25.06	20.61	20.11	24.28	21.13
EBIT Margin(%)	17.11	16.85	22.53	21.46	27.32	28.2	23.91	20.8	19.98	24.51	20.54
Pre Tax Margin(%)	17.1	16.85	22.27	21.22	27.05	27.77	23.69	20.61	19.78	24.34	20.26
PAT Margin (%)	13.9	11.96	14.61	14.67	17.99	17.89	15.26	14.22	14.43	18.24	14.76
Cash Profit Margin (%)	16.06	13.81	16.31	16.89	20.18	20.36	17.39	15.91	16.02	19.57	16.11
ROA(%)	13.68	14.99	21.99	20.1	20.6	26.3	29.54	28.1	25.63	38.41	35.72
ROE(%)	27.94	27.05	33.41	31.02	29.37	39.95	57.17	49.79	42.74	71.64	83.3
ROCE(%)	34.38	38.1	51.51	45.4	44.56	62.65	88.18	71.48	58.05	93.58	110.39
Receivable days	11.08	13.86	14.74	15.47	20.48	21.31	20.91	20.43	21.14	15.76	15.58
Inventory Days	22.06	22.69	20.96	18.37	19.15	23	22.37	20.25	24.83	23.2	22.61
Payable days	142.58	119.29	97.67	119.33	143.65	137.09	148.01	140.88	178.06	202.36	179.37
PER(x)	39.26	44.34	45.78	63.52	48.24	60.36	85.8	82.91	76.11	66.38	75.57
Price/Book(x)	10.21	11.19	13.79	17.89	12.37	50.4	40.57	38.98	29.04	63.2	62.36
Dividend Yield(%)	1.03	0.9	0.65	0.45	0.57	4.83	0.4	0.82	1.03	2.36	1.19
EV/Net Sales(x)	5.35	5.24	6.61	9.16	8.49	11.21	12.93	11.61	10.68	11.92	10.99
EV/Core EBITDA(x)	27.62	27.86	27.06	38.22	27.84	35.05	49.64	51.63	49.49	46.13	50.19
Net Sales Growth(%)	29.37	30.01	21.59	13.79	-2.5	1.98	5.81	20.02	1.87	19.06	9.14
EBIT Growth(%)	26.18	28.32	62.72	8.77	26.7	6.3	-13.94	4.38	-2.1	46.01	-8.52
PAT Growth(%)	20.16	12.1	48.62	14.61	22.06	2.42	-13.44	11.89	3.33	50.5	-11.67
EPS Growth(%)	20.16	12.1	48.62	14.61	22.06	2.42	-13.44	11.89	3.33	50.5	-11.67
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0	0
Current Ratio(x)	1.93	1.91	2.02	1.9	3.19	1.04	1.43	1.66	2.22	1.34	1.32
Quick Ratio(x)	1.72	1.64	1.78	1.73	2.94	0.73	1.21	1.35	1.87	1.04	1.05
Interest Cover(x)	7435	0	86.4	88.55	102.36	65.47	110.36	111.83	98.84	143.37	71.61
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

P&G Hygiene Shareholding Pattern

#	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Promoter	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64
FII	2.46	2.52	2.53	2.57	2.63	2.25	2.03	1.68	1.12	1.05
DII	13.53	13.5	13.57	13.48	13.47	13.89	14.19	14.57	15.28	15.44
Public	13.38	13.34	13.27	13.31	13.26	13.22	13.14	13.12	12.96	12.87
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Promoter	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29
FII	0.08	0.08	0.08	0.08	0.09	0.07	0.07	0.05	0.04	0.03
DII	0.44	0.44	0.44	0.44	0.44	0.45	0.46	0.47	0.5	0.5
Public	0.43	0.43	0.43	0.43	0.43	0.43	0.43	0.43	0.42	0.42
Others	0	0	0	0	0	0	0	0	0	0
Total	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 66%
Debtor days have improved from 202.36 to 179.37days.
Company is almost debt free.

Cons

Stock is trading at 42.7 times its book value.
The company has delivered a poor profit growth of 5% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.